Azoles Flashcards
Azoles
Work by inhibiting fungal cytochrome P450- decreasing ergosterol production
This will cause drug interactions- most can be dealt with by dose adjustment; adjustment needs to be readjusted when the interactor is completed
Many different agents with variable spectrums and toxicity profiles
MOA
All azoles inhibit fungal CYP P450 14-alpha demethylase, inhibiting the conversion of lanosterol into ergosterol (which is a component of the fungal cell membrane)
Fluconazole
Introduced in 1990
Highly bioavailable
Oral and IV; oral conversion is simple
Highly active against many Candida species
Low incidence of serious adverse reactions
Shift toward non-albicans species has affected its use
Fluconazole Spectrum
Good C. albicans C. tropicalis C. parapsilosis C. lusitaniae Cryp. neoformans Coccidioides immitis
Moderate
C. glabrata (can be susceptible, dose dependent, or resistant)
Poor
Molds
Many dimorphic fungi
C. krusei
Fluconazole Adverse Effects
Generally well tolerated
Can cause hepatotoxicity or rash
Has lower risk for serious drug interactions compared with other azoles, but interactions still occur
QTc prolongation possible
Fluconazole Dosing Issues
Doses for systemic fungal infections may be escalated (especially C. glabrata infections)
Adjust dose with regard to renal function; drug eliminated through urine
Vulvovaginal candidiasis require only one time dose of 150mg of fluconazole
Fluconazole Important Facts
Poorly active against all C. krusei and some C. glabrata
If using for glabrata, best to check susceptibility and give 800mg/day after a loading dose
If lab does not do testing, consider an alternate (like echinocandin)
Often given as prophylaxis against Candida infections in susceptible populations (like ICU patients or some with cancer)
If patient was receiving it and now has yeast in blood, try echinocandin instead (may have fluconazole resistant Candida)
Had high bioavailability (excellent therapy to transition to as patients tolerate oral)
Before committing to definitive course of therapy, test patient’s isolate
Fluconazole Good For
Drug of choice for many infections (like invasive and noninvasive candidiasis and cryptococcal disease
Also used for some dimorphic fungi (like coccidioidomycosis)
Itraconazole
Broader spectrum azole
PK issues have impaired its greater use
Has Aspergillus and other mold species activity
Was once commonly used as step down therapy in aspergillosis; this use has declined due to voriconazole availability
Itraconazole Spectrum
Good C. albicans C. tropicalis C. parapsilosis C. lusitaniae Cryp. neoformans Aspergillus species Many dimorphic fungi
Moderate
C. glabrata
C. krusei
Poor
Mucorales
Many other molds
Itraconazole Adverse Effects
Causes more concerns than fluconazole
Hepatotoxicity
Negative ionotrope; contraindicated in heart failure
Oral solution associated with diarrhea
Stronger inhibitor of CYP P450 enzymes
Long list of drug interactions
QTc prolongation
Itraconazole Important Facts
Capsules have lower bioavailability than oral solution; capsules less preferred for systemic fungal infections
Capsules should always be taken with a full meal
Solution should be taken on an empty stomach
Absorption can be lowered by agents that decrease gastric acidity (PPIs); take the drug with a soda
Because absorption is so erratic and unpredictable, concentrations often monitored
Consider checking a trough if taking for a serious fungal infection and/or long time
Was available in an IV form; discontinued; older books may still reference it- ignore
Itraconazole Good For
Drug of choice for some dimorphic fungi (like histoplasmosis)
Used to have larger role in management and prophylaxis of aspergillosis and other mold infections; largely replaced by voriconazole
Capsules also used for treatment of onychomycosis
Voriconazole
Significant improvement in treatment of mold
Broad spectrum like itraconazole; good activity against Candida and many molds
Well absorbed; available in both highly bioavailable oral formulations and an IV admixture
Superior to AmphoB deoxycholate for invasive aspergillosis- now the drug of choice
Limitations in highly variable PK and long term adverse effects
Voriconazole Spectrum
Good C. albicans C. lusitaniae C. parapsilosis C. tropicalis C. krusei Cryp. neoformans Aspergillus species Many other molds
Moderate
C. glabrata
C. albicans that are fluconazole resistant
Fusarium species
Poor
Mucorales
Voriconazole Adverse Effects
Shares the adverse effects of the azole class (hepatotoxicity, rash, drug interactions)
Also agent specific effects
Renal
IV comes in cyclodextrin solubilizer; accumulates in renal dysfunction; nephrotoxic but less so than than AmphoB
Consider risk/reward with renally insufficient patients
Visual
Seeing wavy lines or halos around bright lights are very common and dose related
Tend to go away with continued use
CNS
Visual and auditory hallucinations (distinct from the common visual effects above)
Not permanent
Tend to occur at higher levels (especially during peak concentration periods)
Dermatologic
Causes sun sensitivity; use sunscreen and avoid excess exposure
Has been used for durations (treatment and prophylaxis) far exceeding those in clinical trials
May be association with prolonged use and certain skin cancers; very important to counsel on reducing sun exposure while on the drug